CURREIO
Curreio develops contract business for structural analysis using cryo-electron microscopy.
CURREIO
Industry:
Analytics Biotechnology Medical Nursing And Residential Care
Founded:
2019-08-01
Address:
Shinjuku, Yamanashi, Japan
Country:
Japan
Website Url:
http://www.curreio.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Apple Mobile Web Clips Icon WordPress Font Awesome Wordpress Plugins Nginx
Similar Organizations
ACM Biolabs
ACM Biolabs develops novel vaccines and antibodies using proprietary artificial cell membrane technology.
ExpressCells
ExpressCells creates custom cell lines for biological research and drug discovery.
Investors List
Beyond Next Ventures
Beyond Next Ventures investment in Venture Round - Curreio
Official Site Inspections
http://www.curreio.com
- Host name: www53.onamae.ne.jp
- IP address: 150.95.219.148
- Location: Japan
- Latitude: 35.69
- Longitude: 139.69
- Timezone: Asia/Tokyo
More informations about "Curreio"
キュライオ | クライオ電子顕微鏡で創薬に新たな風を
Curreio Cryo-EM Cycle Curreio Cryo-EM Cycleは、クライオ電子顕微鏡単粒子解析法を主に使った新しいスクリーニング方法です。 キュライオ独自技術でもご紹介したとおり、当社は …See details»
Company Profile - Curreio
Curreio, Inc. HQ Location: Room 357, South Clinical Research Laboratory, Tokyo University, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan, 113-8485: Representative: CEO Motoki Nakai: …See details»
Curreio - Crunchbase Company Profile & Funding
Curreio is a drug discovery business utilizing structural analysis using a cryo-electron microscope. Their product provides structural analysis technology that allows observation by freezing the in …See details»
Curreio | Realization of a safer and healthier lives
Curreio, Inc. HQ Location: Room 357, South Clinical Research Laboratory, Tokyo University, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan, 113-8485: Representative: CEO Motoki Nakai: Establishment: August 2019: Capital: Approximately 400 …See details»
Curreio, Inc. - LinkedIn
Curreio, Inc. Pharmaceutical Manufacturing 文京区, 東京都 63 followers Curreio, is a biotech company specialized in the R&D based on structural analysis using a Cryo-electron microscope.See details»
Curreio Company Profile 2024: Valuation, Funding & Investors
Jun 1, 2021 When was Curreio founded? Curreio was founded in 2019. Where is Curreio headquartered? Curreio is headquartered in Tokyo, Japan. What is the size of Curreio? …See details»
Curreio - Overview, News & Similar companies | ZoomInfo.com
Jun 8, 2023 Who is Curreio. Curreio is a drug discovery startup company established in August 2019, specializing in cryo-EM structural analysis technology. Curreio has unique technologies …See details»
Curreio - Products, Competitors, Financials, Employees, …
Curreio is a biotechnology company focused on drug discovery using cryo-electron microscopy (Cryo-EM) in the pharmaceutical industry. Use the CB Insights Platform to explore Curreio's …See details»
Curreio - Funding, Financials, Valuation & Investors - Crunchbase
Curreio is a biotechnology platform that provides contract business for structural analysis using cryo-electron microscopy. Search Crunchbase. ... How much funding has this organization …See details»
Curreio, Inc. - VentureRadar
Website: https://curreio.com/ Develops a Structure-Based Drug Discovery (SBDD) platform utilizing Cryo-electron microscope (Cryo-EM) technology for innovative ...See details»
会社概要 - キュライオ
会 社 名株式会社キュライオ（Curreio,Inc.）所 在 地東京都文京区本郷7丁目3-1 東京大学 南研究棟 357号室代 表代表取締役CEO 中井基樹設 立2019年8月資 本 金 約4億円（資本準備金含 …See details»
株式会社キュライオ、新経営体制のお知らせ
Oct 10, 2023 株式会社キュライオ（代表取締役ceo：中井基樹、本社：東京都新宿区）は、経営体制の一層の強化を目的とし2023年10月に開催された株主総会を経 ...See details»
クライオ電顕構造解析の株式会社キュライオ、2.6億円の資金調達 …
株式会社キュライオのプレスリリース（2023年3月22日 09時00分）クライオ電顕構造解析の株式会社キュライオ、2.6億円の資金調達を実施。シリーズa ...See details»
株式会社キュライオ - スピーダ スタートアップ情報 ...
Feb 26, 2024 自社技術を用いた新規タンパク質構造の同定、標的タンパク質の構造解析等を実施。 クライオ電子顕微鏡単粒子解析法を主に使った新規スクリーニング方法「Curreio Cryo …See details»
株式会社キュライオの会社情報と資金調達 | NIKKEI COMPASS
★クライオ電顕技術のキュライオ、シリーズAで計5．7億円の資金調達を完了... （20230322） クライオ電子顕微鏡（以下、クライオ電顕）を使った ...See details»
Curreio Raises 260 million Yen from Institutional Investors in Series …
Mar 20, 2023 Curreio Inc. is a biotechnology company found in 2019, Tokyo Japan, specialized in Cryo-EM structural analysis technology. The origination of Curreio’s Cryo-EM technology is …See details»
株式会社キュライオ、事業拡大に伴うラボの移転・増床のお知らせ
株式会社キュライオのプレスリリース（2022年2月16日 13時00分）株式会社キュライオ、事業拡大に伴うラボの移転・増床のお ...See details»
Curreio - Drug Discovery World (DDW)
Curreio . Drug discovery agreement will combine AI and cryo-EM analysis. 12 June 2023. As part of a new collaboration, Iktos’ generative design technology and Curreio’s cryo-electron …See details»
News Release | Curreio
Mar 22, 2023 Curreio and Iktos Announce Collaboration in New Drug Discovery. Tokyo, Japan, 06, 08, 2023 – Curreio, Inc. (Curreio), a Japanese company specializing in structural analysis …See details»
Business - Curreio
We are working on a drug discovery based on structural analysis using a Cryo-electron microscope (Cryo-EM).What is a Cryo-EM? Introduction of research achievements related to …See details»